|
|
|
1
|
Nallamshetty S, Crook M, Boehm M, Yoshimoto T, Olive M, Nabel EG.
The cell cycle regulator p27Kip1 interacts with MCM7, a DNA replication licensing factor, to inhibit initiation of DNA replication.
FEBS Lett 579(29): 6529-36, 2005.
[Text Abstract on PubMed]
|
|
|
2
|
Boehm M, Olive M, True AL, Crook MF, San H, Qu X, Nabel EG.
Bone marrow-derived immune cells regulate vascular disease through a p27(Kip1)-dependent mechanism.
J Clin Invest 114(3): 419-26, 2004.
[Text Abstract on PubMed]
|
|
|
3
|
Li R, Faria TN, Boehm M, Nabel EG, Gudas LJ.
Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
Exp Cell Res 294(1): 290-300, 2004.
[Text Abstract on PubMed]
|
|
|
4
|
Boehm M, Nabel EG.
The cell cycle and cardiovascular diseases.
Prog Cell Cycle Res 5: 19-30, 2003.
[Text Abstract on PubMed]
|
|
|
5
|
Engel FB, Hauck L, Boehm M, Nabel EG, Dietz R, von Harsdorf R.
p21(CIP1) Controls proliferating cell nuclear antigen level in adult cardiomyocytes.
Mol Cell Biol 23(2): 555-65, 2003.
[Text Abstract on PubMed]
|
|
|
6
|
Boehm M, Nabel EG.
Angiotensin-converting enzyme 2--a new cardiac regulator.
N Engl J Med 347(22): 1795-7, 2002.
[Text Abstract on PubMed]
|
|
|
7
|
Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, Nabel EG.
A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.
EMBO J 21(13): 3390-401, 2002.
[Text Abstract on PubMed]
|
|
|
8
|
Nabel EG, Boehm M, Akyurek LM, Yoshimoto T, Crook MF, Olive M, San H, Qu X.
Cell cycle signaling and cardiovascular disease.
Cold Spring Harb Symp Quant Biol 67: 163-70, 2002.
[Text Abstract on PubMed]
|
|
|
9
|
Boehm M, Nabel EG.
Cell cycle and cell migration: new pieces to the puzzle.
Circulation 103(24): 2879-81, 2001.
[Text Abstract on PubMed]
|
|
|
10
|
Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG.
Heme oxygenase-1 protects against vascular constriction and proliferation.
Nat Med 7(6): 693-8, 2001.
[Text Abstract on PubMed]
|
|
|
11
|
Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG.
Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
Circulation 101(17): 2022-5, 2000.
[Text Abstract on PubMed]
|
|
|